Sterne Agee Starts Endo Pharmaceuticals (ENDP) at Buy
Tweet
Share
E-mailGet Alerts ENDP Hot Sheet
Price: $0.29 --0%
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Rating Summary:
14 Buy, 15 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 6
Join SI Premium – FREE
Sterne Agee initiated coverage on Endo Pharmaceuticals (NASDAQ: ENDP) with a Buy rating and a price target of $66.00.
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.
Shares of Endo Pharmaceuticals Holdings Inc closed at $56.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JMP Securities Starts The RMR Group Inc. (RMR) at Market Perform, 'Pure-Pay'
- Morgan Stanley Upgrades Shopify (SHOP) to Overweight, 'Still Operating Leverage Left to Realize'
- Loop Capital Starts Instacart (CART) at Buy, 'Leading a Massive and Underpenetrated Category'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Sterne AgeeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
